BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 33012206)

  • 1. Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications.
    Muralitharan RR; Jama HA; Xie L; Peh A; Snelson M; Marques FZ
    Hypertension; 2020 Dec; 76(6):1674-1687. PubMed ID: 33012206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease.
    Kaye DM; Shihata WA; Jama HA; Tsyganov K; Ziemann M; Kiriazis H; Horlock D; Vijay A; Giam B; Vinh A; Johnson C; Fiedler A; Donner D; Snelson M; Coughlan MT; Phillips S; Du XJ; El-Osta A; Drummond G; Lambert GW; Spector TD; Valdes AM; Mackay CR; Marques FZ
    Circulation; 2020 Apr; 141(17):1393-1403. PubMed ID: 32093510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet-related gut microbial metabolites and sensing in hypertension.
    R Muralitharan R; Marques FZ
    J Hum Hypertens; 2021 Feb; 35(2):162-169. PubMed ID: 32733062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism?
    Jama HA; Beale A; Shihata WA; Marques FZ
    Cardiovasc Res; 2019 Jul; 115(9):1435-1447. PubMed ID: 30951169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Dietary Fibre, Acting via the Gut Microbiome, Lowers Blood Pressure.
    Xu C; Marques FZ
    Curr Hypertens Rep; 2022 Nov; 24(11):509-521. PubMed ID: 35838884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
    Sivaprakasam S; Prasad PD; Singh N
    Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-chain free-fatty acid G protein-coupled receptors in colon cancer.
    Moniri NH; Farah Q
    Biochem Pharmacol; 2021 Apr; 186():114483. PubMed ID: 33631190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Chain Fatty Acid Receptors and Blood Pressure Regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021.
    Xu J; Moore BN; Pluznick JL
    Hypertension; 2022 Oct; 79(10):2127-2137. PubMed ID: 35912645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.
    Natarajan N; Hori D; Flavahan S; Steppan J; Flavahan NA; Berkowitz DE; Pluznick JL
    Physiol Genomics; 2016 Nov; 48(11):826-834. PubMed ID: 27664183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Host energy regulation via SCFAs receptors, as dietary nutrition sensors, by gut microbiota].
    Kimura I
    Yakugaku Zasshi; 2014; 134(10):1037-42. PubMed ID: 25274213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.
    Poll BG; Cheema MU; Pluznick JL
    Physiology (Bethesda); 2020 Jul; 35(4):275-284. PubMed ID: 32490748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
    Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond gut feelings: how the gut microbiota regulates blood pressure.
    Marques FZ; Mackay CR; Kaye DM
    Nat Rev Cardiol; 2018 Jan; 15(1):20-32. PubMed ID: 28836619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment.
    Yang F; Chen H; Gao Y; An N; Li X; Pan X; Yang X; Tian L; Sun J; Xiong X; Xing Y
    Biomed Pharmacother; 2020 Oct; 130():110503. PubMed ID: 34321175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interplay between Maternal and Post-Weaning High-Fat Diet and Gut Microbiota in the Developmental Programming of Hypertension.
    Hsu CN; Hou CY; Lee CT; Chan JYH; Tain YL
    Nutrients; 2019 Aug; 11(9):. PubMed ID: 31443482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension Programmed by Perinatal High-Fat Diet: Effect of Maternal Gut Microbiota-Targeted Therapy.
    Hsu CN; Hou CY; Chan JYH; Lee CT; Tain YL
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31810197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enzymatically modified chestnut starch on the gut microbiome, microbial metabolome, and transcriptome of diet-induced obese mice.
    Lee ES; Song EJ; Nam YD; Nam TG; Kim HJ; Lee BH; Seo MJ; Seo DH
    Int J Biol Macromol; 2020 Feb; 145():235-243. PubMed ID: 31870873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.
    Marques FZ; Nelson E; Chu PY; Horlock D; Fiedler A; Ziemann M; Tan JK; Kuruppu S; Rajapakse NW; El-Osta A; Mackay CR; Kaye DM
    Circulation; 2017 Mar; 135(10):964-977. PubMed ID: 27927713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel SCFA receptor, the microbiota, and blood pressure regulation.
    Pluznick J
    Gut Microbes; 2014; 5(2):202-7. PubMed ID: 24429443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.